ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2024

Jul 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2024-07-02

Reporting Person: Oliver Tracie (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-02	Common Stock	S	9394	$25.28	Disposed	127107	Direct

Footnotes

F1: Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: Partial disposition of RSUs to satisfy tax withholding obligations.

F3: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.